Scinai Immunotherapeutics (SCNI) Gains from Investment Securities (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Gains from Investment Securities for 2 consecutive years, with $510.4 million as the latest value for Q4 2025.

• Quarterly Gains from Investment Securities rose 424.98% to $510.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $510.4 million through Dec 2025, up 424.98% year-over-year, with the annual reading at $510.4 million for FY2025, 424.98% up from the prior year.
• Gains from Investment Securities hit $510.4 million in Q4 2025 for Scinai Immunotherapeutics, up from $97.2 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $510.4 million in Q4 2025 to a low of $97.2 million in Q4 2024.

Peer Comparison